300 related articles for article (PubMed ID: 30744452)
1. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
Sobieraj P; Lewandowski J; Siński M; Symonides B; Gaciong Z
J Am Heart Assoc; 2019 Feb; 8(4):e010811. PubMed ID: 30744452
[TBL] [Abstract][Full Text] [Related]
2. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
3. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
6. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study.
Franklin SS; Gokhale SS; Chow VH; Larson MG; Levy D; Vasan RS; Mitchell GF; Wong ND
Hypertension; 2015 Feb; 65(2):299-305. PubMed ID: 25421982
[TBL] [Abstract][Full Text] [Related]
7. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
[TBL] [Abstract][Full Text] [Related]
8. Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.
Sobieraj P; Lewandowski J; Siński M; Gaciong Z
J Clin Hypertens (Greenwich); 2019 Jul; 21(7):911-918. PubMed ID: 31169350
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
[TBL] [Abstract][Full Text] [Related]
10. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
12. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
[TBL] [Abstract][Full Text] [Related]
13. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
[TBL] [Abstract][Full Text] [Related]
14. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
[TBL] [Abstract][Full Text] [Related]
15. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
[TBL] [Abstract][Full Text] [Related]
16. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
Leitão L; Soares-Dos-Reis R; Neves JS; Baptista RB; Bigotte Vieira M; Mc Causland FR
Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
[TBL] [Abstract][Full Text] [Related]
17. Diastolic Blood Pressure J-Curve Phenomenon in a Tertiary-Care Hypertension Clinic.
Lip S; Tan LE; Jeemon P; McCallum L; Dominiczak AF; Padmanabhan S
Hypertension; 2019 Oct; 74(4):767-775. PubMed ID: 31422693
[TBL] [Abstract][Full Text] [Related]
18. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
[TBL] [Abstract][Full Text] [Related]
19. J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial.
Attar A; Nouri F; Borazjani R; Sayadi M
PLoS One; 2020; 15(10):e0240102. PubMed ID: 33002071
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
Attar A; Sayadi M; Jannati M
Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
